Athersys
ATHX
#10565
Rank
S$1.07 M
Marketcap
S$0.01749
Share price
-33.50%
Change (1 day)
-98.94%
Change (1 year)

Revenue for Athersys (ATHX)

Revenue in 2023 (TTM): S$0.1 Million

According to Athersys's latest financial reports the company's current revenue (TTM ) is S$0.1 Million. In 2022 the company made a revenue of S$7.13 Million a decrease over the revenue in the year 2021 that were of S$7.45 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Athersys from 2007 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) S$0.1 M-98.49%
2022 S$7.13 M-4.25%
2021 S$7.45 M293.49%
2020 S$1.89 M-74.53%
2019 S$7.43 M-77.06%
2018 S$32.42 M752.81%
2017 S$3.8 M-83.82%
2016 S$23.5 M61.33%
2015 S$14.56 M3754.65%
2014 S$0.37 M-60.49%
2013 S$0.95 M-87.62%
2012 S$7.72 M-42.33%
2011 S$13.39 M16.34%
2010 S$11.51 M279.89%
2009 S$3.03 M-31.74%
2008 S$4.44 M-5.34%
2007 S$4.69 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
S$46.61 B 44,963,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$81.36 B 78,482,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$62.24 B 60,042,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
S$2.85 B 2,752,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$119.41 B 115,186,150.00%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
S$0.47 B 455,961.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
S$0.48 M 366.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$83.24 B 80,293,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$61.58 B 59,406,251.25%๐Ÿ‡ซ๐Ÿ‡ท France